Amgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared Holz

February 8, 2024

Jared Holz, Mizuho, joins ‘Closing Bell Overtime’ to talk Amgen’s obesity drug trial results.

Mizuho news from around the globe